Close
Kayoko Shioda

Epidemiologist

Education

Affiliations

Bio

Kayoko is a Japanese veterinarian and infectious disease epidemiologist/modeler. She is interested in modeling the transmission of pathogens among/between humans, animals, and the environment in order to understand how to best mitigate the health risks. She works at Emory University as an epidemiologist in two labs: the Freeman Lab in the Department of Environmental Health and the Lopman Lab in the Department of Epidemiology. Her projects focus on One Health issues in low- and middle-income countries in the Freeman Lab and COVID-19 modeling in the Lopman Lab. She obtained a Doctor of Veterinary Medicine (DVM) from the University of Tokyo in 2012 and a Master of Public Health (MPH) from Emory University in 2014. She had worked in the Division of Viral Diseases at the Centers for Disease Control and Prevention (CDC) in Atlanta from 2014-2016 as an ORISE fellow. She completed her Ph.D. training with Drs. Daniel Weinberger, Virginia Pitzer, and Joshua Warren at Yale School of Public Health in August 2020.

Preferred Pronouns

She/her/hers

Personal Academic Website

Research/Topics of Interest

Agent-based models
Apply models to public health
Between-host modeling
Compartmental models
Geospatial models
Machine learning models
New methods development
Outbreak science
Public health application of models
Public health policy/interventions
Science communication
Social networks/contact patterns
Spatial transmission patterns
Statistical models
Surveillance/case detection
Time-series models
Vaccines
Climate change
Zoonosis
Veterinary medicine
One Health

Pathogens/Diseases of Main Interest/Expertise

COVID-19
Diarrheal diseases
Neglected tropical diseases
Respiratory diseases
Vaccine-preventable diseases
Zoonoses

Countries of Work/Collaboration

United States
Mozambique

Projects

Papers

Nelson KN, Siegler AJ, Sullivan PS, Bradley H, Hall E, Luisi N, Hipp-Ramsey P, Sanchez T, Shioda K, Lopman BA. (2022). Nationally representative social contact patterns among U.S. adults, August 2020-April 2021. Epidemics, (40)

Nelson KN, Siegler AJ, Sullivan PS, Bradley H, Hall E, Luisi N, Hipp-Ramsey P, Sanchez T, Shioda K, Lopman BA. (2022). Nationally Representative Social Contact Patterns among U.S. adults, August 2020-April 2021. medRxiv : the preprint server for health sciences

Lau MSY, Liu C, Siegler AJ, Sullivan PS, Waller LA, Shioda K, Lopman BA. (2022). Post-lockdown changes of age-specific susceptibility and its correlation with adherence to social distancing measures. Scientific reports, 12(1)

Shioda K, Lopman B. (2022). How to interpret the total number of SARS-CoV-2 infections. Lancet

Shioda K, Cai J, Warren JL, Weinberger DM. (2021). Incorporating Information on Control Diseases Across Space and Time to Improve Estimation of the Population-level Impact of Vaccines. Epidemiology (Cambridge, Mass.), 32(3)

Lopman BA, Shioda K, Nguyen Q, Beckett SJ, Siegler AJ, Sullivan PS, Weitz JS. (2021). A framework for monitoring population immunity to SARS-CoV-2. Annals of epidemiology

Chamberlain AT, Toomey KE, Bradley H, Hall EW, Fahimi M, Lopman BA, Luisi N, Sanchez T, Drenzek C, Shioda K, Siegler AJ, Sullivan PS. (2021). Cumulative incidence of SARS-CoV-2 infections among adults in Georgia, USA, August-December 2020. The Journal of infectious diseases

Kleynhans J, Tempia S, Shioda K, von Gottberg A, Weinberger DM, Cohen C. (2021). Estimated impact of the pneumococcal conjugate vaccine on pneumonia mortality in South Africa, 1999 through 2016: An ecological modelling study. PLoS medicine, 18(2)

Sullivan PS, Siegler AJ, Shioda K, Hall EW, Bradley H, Sanchez T, Luisi N, Valentine-Graves M, Nelson KN, Fahimi M, Kamali A, Sailey C, Lopman BA. (2021). SARS-CoV-2 cumulative incidence, United States, August-December 2020. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Shioda K, Lau MS, Kraay AN, Nelson KN, Siegler AJ, Sullivan PS, Collins MH, Weitz JS, Lopman BA. (2021). Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies. Epidemiology (Cambridge, Mass.)

Lamba K, Bradley H, Shioda K, Sullivan PS, Luisi N, Hall EW, Mehrotra ML, Lim E, Jain S, Kamali A, Sanchez T, Lopman BA, Fahimi M, Siegler AJ. (2021). SARS-CoV-2 Cumulative Incidence and Period Seroprevalence: Results From a Statewide Population-Based Serosurvey in California. Open forum infectious diseases, 8(8)

Shioda K, Toscano CM, Valenzuela MT, Huarcaya WV, Warren JL, Weinberger DM, de Oliveira LH. (2020). Impact of pneumococcal conjugate vaccine uptake on childhood pneumonia mortality across income levels in Brazil, Colombia, and Peru. Gates open research, (4)

Shioda K, Lau MS, Kraay AN, Nelson KN, Siegler AJ, Sullivan PS, Collins MH, Weitz JS, Lopman BA. (2020). Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies. medRxiv : the preprint server for health sciences

Shioda K, Weinberger DM, Mori M. (2020). Navigating Through Health Care Data Disrupted by the COVID-19 Pandemic. JAMA internal medicine, 180(12)

Fauver JR, Petrone ME, Hodcroft EB, Shioda K, Ehrlich HY, Watts AG, Vogels CBF, Brito AF, Alpert T, Muyombwe A, Razeq J, Downing R, Cheemarla NR, Wyllie AL, Kalinich CC, Ott IM, Quick J, Loman NJ, Neugebauer KM, Greninger AL, Jerome KR, Roychoudhury P, Xie H, Shrestha L, Huang ML, Pitzer VE, Iwasaki A, Omer SB, Khan K, Bogoch II, Martinello RA, Foxman EF, Landry ML, Neher RA, Ko AI, Grubaugh ND. (2020). Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States. Cell, 181(5)

Shioda K, Schuck-Paim C, Taylor RJ, Lustig R, Simonsen L, Warren JL, Weinberger DM. (2019). Challenges in Estimating the Impact of Vaccination with Sparse Data. Epidemiology (Cambridge, Mass.), 30(1)

Warren JL, Shioda K, Kürüm E, Schuck-Paim C, Lustig R, Taylor RJ, Simonsen L, Weinberger DM. (2017). Impact of Pneumococcal Conjugate Vaccines on Pneumonia Hospitalizations in High- and Low-Income Subpopulations in Brazil. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 65(11)

Kayoko Shioda, Leslie Barclay, Sylvia Becker-Dreps, Filemon Bucardo-Rivera, Philip J Cooper, Daniel C Payne, Jan Vinjé, Benjamin A Lopman. (2017). Can use of viral load improve norovirus clinical diagnosis and disease attribution?. Open Forum Infectious Diseases, 4(3)

Mori M, Hebson C, Shioda K, Elder RW, Kogon BE, Rodriguez FH, Jokhadar M, Book WM. (2016). Catheter-measured Hemodynamics of Adult Fontan Circulation: Associations with Adverse Event and End-organ Dysfunctions. Congenital heart disease, 11(6)

Mori M, Shioda K, Elder RW, Pernetz MA, Rodriguez FH 3rd., Rangosch A, Kogon BE, Book WM. (2016). Superior Mesenteric Arterial Flow Pattern is Associated with Major Adverse Events in Adults with Fontan Circulation. Pediatric cardiology, 37(6)

If you’d like to update your profile, please email modifications to questions@midasnetwork.us.

This site is registered on wpml.org as a development site.